tiprankstipranks
Trending News
More News >
Silence Therapeutics (SLN)
NASDAQ:SLN
US Market

Silence Therapeutics (SLN) Technical Analysis

Compare
155 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
4Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Silence Therapeutics’s (SLN) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Silence Therapeutics is a Sell.
Silence Therapeutics’s (SLN) 20-Day exponential moving average is 3.03, while Silence Therapeutics’s (SLN) share price is $3.05, making it a Buy.
Silence Therapeutics’s (SLN) 50-Day exponential moving average is 3.87, while Silence Therapeutics’s (SLN) share price is $3.05, making it a Sell.

Silence Therapeutics (SLN) Pivot Points

Apr 24, 2025, 03:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.67
2.82
2.93
3.08
3.19
3.34
3.45
Fibonacci
2.82
2.92
2.98
3.08
3.18
3.24
3.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Silence Therapeutics (SLN) Moving Averages

Apr 24, 2025, 03:57 PM
Period
Simple
Exponential
MA5
3.12Buy
3.10Buy
MA10
2.81Buy
2.97Buy
MA20
2.83Buy
3.03Buy
MA50
3.75Sell
3.87Sell
MA100
5.10Sell
6.02Sell
MA200
11.40Sell
10.96Sell
Silence Therapeutics’s (SLN) 10-Day exponential moving average is 2.97, while Silence Therapeutics’s (SLN) share price is $3.05, making it a Buy.
Silence Therapeutics’s (SLN) 100-Day exponential moving average is 6.02, while Silence Therapeutics’s (SLN) share price is $3.05, making it a Sell.
Silence Therapeutics’s (SLN) stock price is $3.05 and Silence Therapeutics’s (SLN) 50-day simple moving average is 3.75, creating a Sell signal.
Silence Therapeutics’s (SLN) stock price is $3.05 and Silence Therapeutics’s (SLN) 100-day simple moving average is 5.10, creating a Sell signal.
Silence Therapeutics’s (SLN) stock price is $3.05 and Silence Therapeutics’s (SLN) 200-day simple moving average is 11.40, creating a Sell signal.

Silence Therapeutics (SLN) Technical Indicators

Apr 24, 2025, 03:57 PM
Name
Value
Implied Action
RSI (14)
52.86
Neutral
STOCH (9,6)
93.07
Sell
STOCHRSI (14)
93.07
Sell
MACD (12,26)
-0.20
Sell
ADX (14)
29.14
Neutral
Williams %R
-5.59
Sell
CCI (14)
86.78
Neutral
ATR (14)
0.38
-
Ultimate Oscillator
62.02
Neutral
ROC
14.88
Buy
Silence Therapeutics’s (SLN) Relative Strength Index (RSI) is 52.86, creating a Neutral signal.
Silence Therapeutics’s (SLN) Trend Strength Indicator (ADX) is 29.14, creating a Neutral signal.
Silence Therapeutics’s (SLN) Commodity Channel Index (CCI) is 86.78, creating a Neutral signal.
Silence Therapeutics’s (SLN) Price Rate of Change (ROC) is 14.88, creating a Buy signal.

FAQ

Is SLN a Buy, Hold, or Sell?
Based on SLN’s technical indicators, SLN is a Hold.
    What is SLN’s RSI (14)?
    SLN’s RSI (14) is 52.86, which suggests SLN is a Neutral.
      What is SLN’s MACD?
      SLN’s MACD is -0.20, which suggests SLN is a Sell.
        What is SLN’s 5-day moving average?
        SLN’s 5-day moving average is 3.12, which suggests SLN is a Buy.
          What is SLN’s 20-day moving average?
          SLN 20-day moving average is 2.83, which suggests SLN is a Buy.
            What is SLN’s 50-day moving average?
            SLN’s 50-day moving average is 3.75, which suggests SLN is a Sell.
              What is SLN’s 200-day moving average?
              SLN’s 200-day moving average is 11.40, which suggests SLN is a Sell.
                What is SLN’s Williams % R (14)?
                SLN’s Williams % R (14) is -5.59, which suggests SLN is a Sell.
                  What is SLN’s CCI (14)?
                  SLN’s CCI (14) is 86.78, which suggests SLN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis